Literature DB >> 10786665

Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.

F F Zheng1, S D Kuduk, G Chiosis, P N Münster, L Sepp-Lorenzino, S J Danishefsky, N Rosen.   

Abstract

Geldanamycin (GM) is a natural antibiotic that binds Hsp90 and induces the degradation of receptor tyrosine kinases, steroid receptors, and Raf. It is a potent inhibitor of cancer cells that overexpress HER-kinases, but its effects on other important proteins may cause significant toxicity and limit its clinical use. We report the synthesis and identification of a GM dimer, GMD-4c, which had selective activity against HER-kinases. Selectivity was a function of linker length and required two intact GM moieties. GMD-4c is a potent inducer of G1 block and apoptosis of breast cancer cell lines that overexpress HER2, but does not appreciably inhibit the growth of 32D cells that lack HER-kinases. GMD-4c could be useful in the treatment of carcinomas dependent on HER-kinases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786665

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Pharmacological approaches to defining the role of chaperones in aging and prostate cancer progression.

Authors:  Sarah A Harvey; Keith O Jensen; Lynne W Elmore; Shawn E Holt
Journal:  Cell Stress Chaperones       Date:  2002-04       Impact factor: 3.667

2.  Impact of linker length on the activity of PROTACs.

Authors:  Kedra Cyrus; Marie Wehenkel; Eun-Young Choi; Hyeong-Jun Han; Hyosung Lee; Hollie Swanson; Kyung-Bo Kim
Journal:  Mol Biosyst       Date:  2010-10-04

Review 3.  Chemical approaches to controlling intracellular protein degradation.

Authors:  John S Schneekloth; Craig M Crews
Journal:  Chembiochem       Date:  2005-01       Impact factor: 3.164

4.  Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.

Authors:  Mads Lerdrup; Silas Bruun; Michael V Grandal; Kirstine Roepstorff; Malene M Kristensen; Anette M Hommelgaard; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2007-07-11       Impact factor: 4.138

5.  Cytotoxic small molecule dimers and their inhibitory activity against human breast cancer cells.

Authors:  M Kyle Hadden; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2007-07-13       Impact factor: 2.823

6.  A structurally simplified analogue of geldanamycin exhibits neuroprotective activity.

Authors:  Manikandadas M Madathil; Omar M Khdour; Jennifer Jaruvangsanti; Sidney M Hecht
Journal:  ACS Med Chem Lett       Date:  2013-07-25       Impact factor: 4.345

7.  Geldanamycin selectively targets the nascent form of ERBB3 for degradation.

Authors:  Candice S Gerbin; Ralf Landgraf
Journal:  Cell Stress Chaperones       Date:  2010-01-19       Impact factor: 3.667

8.  Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.

Authors:  Neill Patani; Wen Jiang; Robert Newbold; Kefah Mokbel
Journal:  J Carcinog       Date:  2010-11-12

9.  Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

Authors:  J E Bohonowych; U Gopal; J S Isaacs
Journal:  J Oncol       Date:  2010-06-24       Impact factor: 4.375

Review 10.  Dimeric approaches to anti-cancer chemotherapeutics.

Authors:  M K Hadden; B S J Blagg
Journal:  Anticancer Agents Med Chem       Date:  2008-10       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.